AOD-9604 + CJC-1295 + Ipamorelin dosage chart

Reconstitution steps

1. 1Draw 3.0 mL bacteriostatic water with a sterile syringe.
2. 2Inject slowly down the vial wall; avoid foaming.
3. 3Gently swirl/roll until dissolved (do not shake).
4. 4Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Dosing Cycle & Timing

This protocol runs on a 5 days on / 2 days off cycle.

• Cycle: 5 days on, 2 days off — dose Monday through Friday and rest on the weekend.
• 5 dosing days per week; the 2 off days help limit receptor desensitisation and give injection sites time to recover.
• Keep the dose time consistent on dosing days.
• If a weekday dose is missed, take it the same day if possible — do not dose on an off day to catch up.
• Weekly totals in the supplies and shopping lists are calculated on 5 dosing days, not 7.

Protocol Overview

Concise summary of the once‑daily regimen.

• Goal: Support body composition improvements through combined lipolytic and GH-stimulating mechanisms.
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 200–400 mcg AOD / 100–200 mcg CJC / 100–200 mcg Ip daily with gradual titration.
• Reconstitution: 3.0 mL per 12 mg vial (4 mg/mL total concentration).
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

• Start: 0.10 mL daily (200 mcg AOD / 100 mcg CJC / 100 mcg Ip); increase by ~0.05 mL weekly as tolerated.
• Target: 0.20 mL daily (400 mcg AOD / 200 mcg CJC / 200 mcg Ip) by Week 3.
• Frequency: Once per day (subcutaneous).
• Cycle Length: 8–12 weeks; optional extension to 16 weeks.
• Timing: Morning or before bed on an empty stomach; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 28 days per CDC/USP guidelines.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.
• Best administered on an empty stomach (fasting) for optimal GH release.

How This Works

This blend combines three complementary peptides with distinct mechanisms:

Together, these peptides work synergistically to enhance endogenous GH pulsatility and promote favorable changes in body composition similar to exogenous GH therapy.

• AOD-9604 is a modified C-terminal fragment of human growth hormone (amino acids 177–191) that retains the lipolytic and anti-lipogenic properties of GH without stimulating IGF-1 or affecting glucose metabolism.
• CJC-1295 is a long-acting GHRH analog that produces sustained elevations in growth hormone and IGF-1 levels, supporting anabolic processes and fat metabolism.
• Ipamorelin is a selective ghrelin mimetic that stimulates pulsatile GH secretion without significantly increasing ACTH or cortisol, offering a cleaner GH release profile.

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

Potential Benefits

• Supports reduction in fat mass and enhancement of lipolysis.
• May promote lean mass gains through sustained GH and IGF-1 elevation.
• Selective GH release without significant cortisol or prolactin increases.
• AOD-9604 shows a placebo-like safety profile in human studies.

Lifestyle Factors

Complementary strategies for best outcomes.

• Pair with a balanced, protein-forward diet tailored to energy needs.
• Combine resistance training and aerobic activity to reinforce metabolic adaptations.
• Prioritize quality sleep (7–9 hours) to maximize endogenous GH release.
• Manage stress to optimize hormonal balance and recovery.
• Stay hydrated and maintain consistent meal timing.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

• Clean the vial stopper and skin with alcohol; allow to dry.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
• Do not aspirate for subcutaneous injections; inject slowly and steadily.
• Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
• Dispose of used syringes in an approved sharps container; follow local disposal regulations.

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

AOD-9604 + CJC-1295 + Ipamorelin dosage FAQs